UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	September 14, 2026

Accession Number:	0001104659-26-106326
Submission Type:	POS AM
CIK: 0001828185 Company Name: Barinthus Biotherapeutics plc. File Number: 333-265763